Search Results - "Tabarsi, Payam"
-
1
Human Monkeypox
Published in Iranian journal of medical sciences (01-07-2022)“…Human monkeypox virus (MPXV) is a double-stranded DNA virus of the Orthopoxvirus genus of the Poxviridae family. Two genetic clades of the monkeypox virus have…”
Get full text
Journal Article -
2
The Immune Response and Immunopathology of COVID-19
Published in Frontiers in immunology (26-08-2020)“…Coronaviruses were first discovered in the 1960s and are named due to their crown-like shape. Sometimes, but not often, a coronavirus can infect both animals…”
Get full text
Journal Article -
3
Smell dysfunction: a biomarker for COVID‐19
Published in International forum of allergy & rhinology (01-08-2020)“…Background Severe acute respiratory syndrome‐coronavirus‐2 (SARS‐CoV‐2), the virus that causes coronavirus disease 2019 (COVID‐19), is responsible for the…”
Get full text
Journal Article -
4
Cancers Related to Immunodeficiencies: Update and Perspectives
Published in Frontiers in immunology (20-09-2016)“…The life span of patients with primary and secondary immunodeficiency is increasing due to recent improvements in therapeutic strategies. While the incidence…”
Get full text
Journal Article -
5
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study
Published in The Lancet infectious diseases (01-04-2021)“…Rapid increases in cases of COVID-19 were observed in multiple cities in Iran towards the start of the pandemic. However, the true infection rate remains…”
Get full text
Journal Article -
6
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
Published in International immunopharmacology (01-01-2021)“…•Intravenous immunoglobulin (IVIg) administration was not effective in the management of severe COVID-19 cases.•Intravenous immunoglobulin (IVIg)…”
Get full text
Journal Article -
7
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
Published in Transfusion and apheresis science (01-10-2020)“…Since Dec. 2019 the new coronavirus (SARS-CoV-2) has infected millions and claimed life of several hundred thousand worldwide. However, so far no approved…”
Get full text
Journal Article -
8
Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion
Published in Scientific reports (12-01-2021)“…Patients with tuberculous pleural effusion (TPE) or malignant pleural effusions (MPE) frequently have similar pleural fluid profiles. New biomarkers for the…”
Get full text
Journal Article -
9
Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
Published in Frontiers in immunology (22-04-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) has infected over 112M patients and resulted in…”
Get full text
Journal Article -
10
ISG15 deficiency and increased viral resistance in humans but not mice
Published in Nature communications (19-05-2016)“…ISG15 is an interferon (IFN)-α/β-induced ubiquitin-like protein. It exists as a free molecule, intracellularly and extracellularly, and conjugated to target…”
Get full text
Journal Article -
11
Iran's Approach to COVID-19: Evolving Treatment Protocols and Ongoing Clinical Trials
Published in Frontiers in public health (04-09-2020)“…The coronavirus disease 2019 (COVID-19) pandemic is challenging the health care systems around the world and compelling them to timely share their strategies,…”
Get full text
Journal Article -
12
Long COVID‐19 leading to Good's syndrome diagnosis: A clinical case‐report and literature review
Published in Clinical case reports (01-06-2024)“…Key Clinical Message Good's syndrome (GS) in conjunction with a severe COVID‐19 infection, shedding light on the complexities of managing this rare condition…”
Get full text
Journal Article -
13
The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial
Published in Frontiers in pharmacology (19-10-2023)“…Background: Tocilizumab and baricitinib are considered standard treatments for hospitalized COVID-19 patients with an inflammatory status. However, the effects…”
Get full text
Journal Article -
14
COVID-19: Molecular and Cellular Response
Published in Frontiers in cellular and infection microbiology (11-02-2021)“…In late December 2019, a vtiral pneumonia with an unknown agent was reported in Wuhan, China. A novel coronavirus was identified as the causative agent…”
Get full text
Journal Article -
15
Clinical and genomic evaluations of a persistent fatal SARS-CoV-2 infection in a goods syndrome patient: a case report
Published in BMC infectious diseases (19-02-2024)“…The coronavirus disease of 2019 (COVID-19) resulted from an infection by severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) which is the main cause…”
Get full text
Journal Article -
16
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
Published in International immunopharmacology (01-11-2020)“…•The pathophysiology of SARS-CoV-2 infection may be attributed to cytokine release syndrome.•In this syndrome, interleukin 6 is released after the activation…”
Get full text
Journal Article -
17
Transmission electron microscopy study of suspected primary ciliary dyskinesia patients
Published in Scientific reports (11-02-2022)“…Primary ciliary dyskinesia (PCD) is a rare autosomal recessive condition often presenting with chronic respiratory infections in early life. Transmission…”
Get full text
Journal Article -
18
Bovis Bacillus Calmette-Guerin (BCG) infection induces exosomal miRNA release by human macrophages
Published in Journal of translational medicine (12-05-2017)“…Tuberculosis (TB) remains a significant global health concern and its diagnosis is challenging due to the limitations in the specificity and sensitivity of the…”
Get full text
Journal Article -
19
COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper
Published in Basic and clinical neuroscience (01-03-2020)“…Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who…”
Get full text
Journal Article -
20
Pattern recognitions receptors in immunodeficiency disorders
Published in European journal of pharmacology (05-08-2017)“…Pattern recognition receptors (PRRs) recognize common microbial or host-derived macromolecules and have important roles in early activation and response of the…”
Get full text
Journal Article